PR Newswire Clinical TrialsOriginal article
Zepbound linked to lower healthcare costs in adults over age 55 with obesity according to a real-world study
Data ReadoutpositiveZepboundPositive
AI Analysis
Summary
A real-world study demonstrated that Zepbound use in adults over 55 with obesity is associated with lower healthcare costs, reduced hospital admissions, and fewer emergency department visits, supporting the value of the Medicare GLP-1 Bridge program.
Clinical Trial Data
Primary Endpoint
Met
Outcome Details
Real-world study showed Zepbound use in adults over 55 with obesity associated with lower healthcare costs, reduced hospital admissions, and fewer emergency department visits
Importance:6/10
Sentiment:
0.70
obesityreal-world evidencehealthcare costsMedicareGLP-1older adults
Related Companies
Read the original article
Published by PR Newswire Clinical Trials on August 26, 2026 10:45 AM